Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | $0.87 | $0.92 | $0.89 |
| Q2 2025 | 5 | $0.91 | $1.00 | $0.95 |
| Q3 2025 | 5 | $0.90 | $0.98 | $0.94 |
| Q4 2025 | 4 | $0.64 | $0.83 | $0.76 |
| Q1 2026 | 1 | $0.97 | $1.03 | $1.00 |
| Q2 2026 | 1 | $1.00 | $1.06 | $1.03 |
| Q3 2026 | 1 | $0.95 | $1.01 | $0.98 |
| Q4 2026 | 1 | $0.86 | $0.91 | $0.89 |
Organon & Co. last posted its earnings results on Monday, November 10th, 2025. The company reported $1.01 earnings per share for the quarter, topping analysts' consensus estimates of $0.93 by $0.08. The company had revenue of 1.60 B for the quarter and had revenue of 6.40 B for the year. Organon & Co. has generated $3 earnings per share over the last year ($3.33 diluted earnings per share) and currently has a price-to-earnings ratio of 3.71. Organon & Co. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 12th, 2026 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/10/2025 | Q3 2025 | $0.93 | $0.62 | -0.31 | $1.57 B | $1.60 B |
| 08/06/2025 | Q2 2025 | N/A | $0.56 | N/A | $1.55 B | $1.59 B |
| 05/02/2025 | Q1 2025 | N/A | $0.34 | N/A | N/A | $1.51 B |
| 02/28/2025 | Q4 2024 | N/A | $0.42 | N/A | N/A | $1.59 B |
| 11/01/2024 | Q3 2024 | N/A | $1.39 | N/A | $1.56 B | $1.58 B |
| 08/07/2024 | Q2 2024 | N/A | $0.76 | N/A | $1.61 B | $1.61 B |
| 05/03/2024 | Q1 2024 | N/A | $0.78 | N/A | N/A | $1.62 B |
| 02/26/2024 | Q4 2023 | N/A | $2.14 | N/A | N/A | $1.60 B |
| 11/03/2023 | Q3 2023 | N/A | $0.23 | N/A | $1.57 B | $1.52 B |
| 08/09/2023 | Q2 2023 | N/A | $0.95 | N/A | $1.57 B | $1.61 B |
| 05/04/2023 | Q1 2023 | N/A | $0.70 | N/A | $1.54 B | $1.54 B |
| 02/27/2023 | Q4 2022 | N/A | $0.42 | N/A | $1.49 B | $1.49 B |
| 11/03/2022 | Q3 2022 | N/A | $0.89 | N/A | $1.51 B | $1.54 B |
| 08/04/2022 | Q2 2022 | N/A | $0.92 | N/A | $1.53 B | $1.59 B |
| 05/05/2022 | Q1 2022 | N/A | $1.37 | N/A | $1.52 B | $1.57 B |
| 03/21/2022 | Q4 2021 | N/A | $0.80 | N/A | $1.57 B | $1.60 B |
| 11/12/2021 | Q3 2021 | N/A | $1.27 | N/A | $1.58 B | $1.60 B |
| 08/16/2021 | Q2 2021 | N/A | $1.68 | N/A | $1.52 B | $1.62 B |
| 06/21/2021 | Q1 2021 | $1.52 | $1.58 | 0.06 | $1.57 B | $1.51 B |
| 12/30/2020 | Q4 2020 | N/A | $1.45 | N/A | N/A | $1.61 B |
Organon & Co. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 12th, 2026 based offlast year's report dates.
In the previous quarter, Organon & Co. (:OGN) reported $1.01 earnings per share (EPS) to beat the analysts' consensus estimate of $0.93 by $0.08.
The conference call for Organon & Co.'s latest earnings report can be listened to online.
The conference call transcript for Organon & Co.'s latest earnings report can be read online.
Organon & Co. (:OGN) has a recorded annual revenue of $6.40 B.
Organon & Co. (:OGN) has a recorded net income of $864.00 M.Organon & Co. has generated $3.36 earnings per share over the last four quarters.
Organon & Co. (:OGN) has a price-to-earnings ratio of 3.71 and price/earnings-to-growth ratio is -0.13.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED